The make DEEP Human Families Blog

Posts

October 17, 2024

New diabetes clinical trial: Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma

Published on: October 16, 2024 at 11:00PM Conditions : Relapsed Refractory Multiple Myeloma (RRMM) Interventions : Drug: Elranatamab; Drug: Mezigdomide; Drug: Dexamethasone Sponsors : YOUNGIL KOH Not yet recruiting https://ift.tt/3AtgSUj

Search This Blog

The make DEEP Human Families Blog

Posts

The COMET FISHealth Portal

make DEEP Human Families Healthy Experiences Portal

Featured

New diabetes clinical trial: Mezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma

Latest Posts

New diabetes clinical trial: Obesity Doppler in Term Pregnancy

New diabetes clinical trial: Effect of Hyaluronic Acid and Single Dose Corticosteroid Injection to Improve Wound Healing in Controlled Diabetic Patients Post Tooth Extraction.

New diabetes clinical trial: Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity

New diabetes clinical trial: Comparision of Aerobic Exercise to Aerobic Plus Yoga Exercise for Weight Loss in Adults With Overweight or Obesity.

New diabetes clinical trial: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

New diabetes clinical trial: Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

New diabetes clinical trial: Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat

New diabetes clinical trial: Digital InteGrated Behavioral TreatmeNt for Comorbid ObesITy and DeprEssion Among Racial and Ethnic Adults Age 50 and Older

New diabetes clinical trial: Long-term Mortality Post Liver Transplantation in the Era of Modern Immunosuppression.

New diabetes clinical trial: Mechanism Study of Metabolic Response and Health Benefit Induced by Exercise